Although unproven, it is conceivable that the less frequent clones can provide, altruistically, a fitness advantage to the HRAS mutant cells similarly to what has been observed for glioblastoma multiforme [5,8] or for WNT-secreting wild-type HRAS clones supporting HRAS mutants [9]. This evidence concerns the gene HRAS and glioblastoma.